ABBV
AbbVie Inc.
- Depreciation and amortization, 2025
- $8.1B
- YoY, 2025
- −2.9%
- 5-year CAGR
- +4.7%
- 10-year CAGR
- +25.6%
Depreciation and amortization
Depreciation and amortization by fiscal year
| Period | D&A | YoY |
|---|---|---|
| 2025 | $8.1B | −2.9% |
| 2024 | $8.4B | −3.6% |
| 2023 | $8.7B | +2.7% |
| 2022 | $8.5B | −0.6% |
| 2021 | $8.5B | +31.7% |
| 2020 | $6.5B | +220.8% |
| 2019 | $2.0B | +14.3% |
| 2018 | $1.8B | +17.6% |
| 2017 | $1.5B | +26.2% |
| 2016 | $1.2B | +42.2% |
| 2015 | $836M | +6.4% |
| 2014 | $786M | −12.4% |
| 2013 | $897M | −22.0% |
| 2012 | $1.2B | −9.6% |
| 2011 | $1.3B | — |